Calvert Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Calvert Investment Management's AMGN Position: Q1 2017 in Review
Calvert Investment Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 114,881 shares — an estimated $16.8M sold.
Calvert Investment Management first reported a position in AMGN in Q2 2013 and held it in 15 quarters. The position peaked at $34.4M in Q2 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.
- Calvert Investment Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 114,881 Amgen shares in Q1 2017, an estimated $16.8M.
- Calvert Investment Management first reported a position in Amgen in Q2 2013 and held it in 15 quarters.
- Calvert Investment Management's Amgen position peaked at $34.4M in Q2 2015.
- 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.